Aclaris Therapeutics, Inc.
ACRS
23 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 27 11:27 PM | Braden Michael Leonard10% Owner | Sale | 300,000 | $4.53 | $1.4M | 13,950,000(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Feb 5 9:48 PM | James LoeropChief Business Officer | Option Exercise | 20,875 | — | 62,625(D) | View → |
| Feb 3, 2026 | Feb 5 9:45 PM | Neal WalkerDirector, CEO | Option Exercise | 63,475 | — | 190,425(D) | View → |
| Feb 3, 2026 | Feb 5 9:44 PM | Hugh M. DavisDirector, President and COO | Option Exercise | 18,675 | — | 56,025(D) | View → |
| Feb 3, 2026 | Feb 5 9:41 PM | Kevin BalthaserChief Financial Officer | Option Exercise | 22,025 | — | 66,075(D) | View → |
| Feb 1, 2026 | Feb 5 9:38 PM | James LoeropChief Business Officer | Option Exercise | 33,500 | — | 29,500(D) | View → |
| Feb 1, 2026 | Feb 3 10:36 PM | Kevin BalthaserChief Financial Officer | Option Exercise | 14,750 | — | 29,500(D) | View → |
← Previous
Page 2 of 2